This has resulted in new classifications as outlined by the WHO Classification of Tumors of the Central Nervous System.24 For EWS specifically, an integrated genomic analysis of 323 tumors previously diagnosed as cPNET found 2% of those patients were subsequently molecularly identified as EWS. The gene discussed is EWSR1; the disease is medulloblastoma.